Microbix Biosystems Inc. (TSX:MBX)
Canada · Delayed Price · Currency is CAD 0.3200
0.00 (0.00%)
Aug 28, 2026, 9:33 AM EST
Microbix Biosystems Ratios and Metrics
Market cap in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 44 | 37 | 46 | 42 | 71 | 79 | |
Market Cap Growth | 30.42% | -18.87% | 9.25% | -41.05% | -9.88% | 178.12% |
Enterprise Value | 43 | 31 | 39 | 35 | 63 | 77 |
Last Close Price | 0.32 | 0.27 | 0.34 | 0.30 | 0.51 | 0.63 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | - | - | 12.97 | - | 39.63 | 24.33 |
Forward PE | - | 21.67 | 16.75 | 17.43 | 20.40 | 13.70 |
PS Ratio | 2.85 | 1.99 | 1.80 | 2.53 | 3.72 | 4.23 |
PB Ratio | 1.81 | 1.33 | 1.61 | 1.70 | 2.84 | 4.24 |
P/TBV Ratio | 2.10 | 1.54 | 1.90 | 2.07 | 3.02 | 4.65 |
P/FCF Ratio | - | - | 16.84 | - | 49.24 | 91.05 |
P/OCF Ratio | - | - | 10.50 | - | 20.46 | 37.34 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
EV/Sales Ratio | 2.82 | 1.69 | 1.54 | 2.12 | 3.28 | 4.17 |
EV/EBITDA Ratio | - | - | 7.55 | - | 18.80 | 14.38 |
EV/EBIT Ratio | - | - | 10.06 | - | 23.97 | 16.02 |
EV/FCF Ratio | - | - | 14.46 | - | 43.46 | 89.69 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Debt / Equity Ratio | 0.28 | 0.24 | 0.23 | 0.27 | 0.23 | 0.42 |
Debt / EBITDA Ratio | - | 105.91 | 1.19 | - | 1.66 | 1.40 |
Debt / FCF Ratio | - | - | 2.36 | - | 4.05 | 8.95 |
Net Debt / Equity Ratio | -0.02 | -0.19 | -0.23 | -0.20 | -0.31 | -0.12 |
Net Debt / EBITDA Ratio | 0.14 | 38.23 | -1.26 | 2.62 | -2.30 | -0.42 |
Net Debt / FCF Ratio | 0.11 | 6.08 | -2.42 | 2.35 | -5.32 | -2.61 |
Asset Turnover | 0.43 | 0.49 | 0.69 | 0.48 | 0.62 | 0.84 |
Inventory Turnover | 0.86 | 1.12 | 1.64 | 1.64 | 1.64 | 1.74 |
Quick Ratio | 3.17 | 4.94 | 5.05 | 3.63 | 6.25 | 2.73 |
Current Ratio | 6.89 | 8.48 | 7.15 | 5.13 | 8.45 | 3.68 |
Return on Equity (ROE) | -18.23% | -8.01% | 13.30% | -0.16% | 8.22% | 25.69% |
Return on Assets (ROA) | -7.39% | -2.61% | 6.60% | -4.97% | 5.27% | 13.61% |
Return on Invested Capital (ROIC) | -17.96% | -7.13% | 18.05% | -14.82% | 14.90% | 33.35% |
Return on Capital Employed (ROCE) | -13.80% | -4.60% | 11.20% | -8.70% | 8.60% | 20.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Earnings Yield | -11.15% | -6.06% | 7.71% | -0.09% | 2.52% | 4.11% |
FCF Yield | -8.87% | -2.37% | 5.94% | -5.05% | 2.03% | 1.10% |
Buyback Yield / Dilution | 1.62% | -0.48% | -0.42% | 2.67% | -0.00% | -35.14% |